| RENTA 4 MEGATENDENCIAS / SALUD INNOVACION Y BIOTECNOLOGIA MEDICA R | RVI SALUD | 13,811440 | 02/11/2026 | 13,90% | 22,99% | ** |
| STRUCTURED INVESTMENTS SICAV - CROSS ASSET TREND PORTFOLIO E USD | RENT. ABSOLUTA. | 11,385521 | 02/11/2026 | 13,90% | -1,10% | ** |
| AMUNDI FUNDS US EQUITY RESEARCH A2 USD (C) | RVI USA | 48,484308 | 02/11/2026 | 13,89% | · | ND |
| AXA IM US EQUITY QI B USD ACC | RVI USA | 51,524608 | 02/11/2026 | 13,89% | 61,42% | *** |
| BELLEVUE FUNDS (LUX) - BELLEVUE DIVERSIFIED HEALTHCARE I EUR | RVI SALUD | 147,980000 | 02/11/2026 | 13,89% | 28,70% | *** |
| BELLEVUE FUNDS (LUX) - BELLEVUE SUSTAINABLE HEALTHCARE I EUR | RVI SALUD | 200,170000 | 02/11/2026 | 13,89% | 20,92% | ** |
| CT (LUX) GLOBAL REAL ESTATE SECURITIES IU USD | RVI INMOBILIARIO INDIRECTO | 9,770328 | 02/11/2026 | 13,89% | · | ND |
| DWS INVEST TOP DIVIDEND LCH (P) | RVI GLOBAL VALOR | 205,420000 | 02/11/2026 | 13,89% | 50,38% | ** |
| FIRST EAGLE AMUNDI RESILIENT EQUITY FUND AE-C | RVI GLOBAL VALOR | 185,860000 | 02/11/2026 | 13,89% | · | ND |
| GESTION BOUTIQUE IV / TAIL RENTA VARIABLE GLOBAL | RVI GLOBAL | 14,902730 | 29/10/2026 | 13,89% | 53,19% | *** |
